Guanfacine extended release in the treatment of attention-deficit/hyperactivity disorder.
Rostain
Anthony L
AL
Departmentof Psychiatry at the University of Pennsylvania Health System, 3535 Market Street, Room 2007, Philadelphia, PA 19104, USA. rostain@mail.med.upenn.edu
D015746:Abdominal Pain / Q000139:chemically induced; D000293:Adolescent; D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000188:drug therapy*; D002648:Child; D003692:Delayed-Action Preparations / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D016316:Guanfacine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D016896:Treatment Outcome
D000316:Adrenergic alpha-Agonists; D003692:Delayed-Action Preparations; D016316:Guanfacine